Asklepios proresearch
17
2
3
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
17.6%
3 terminated/withdrawn out of 17 trials
62.5%
-24.0% vs industry average
6%
1 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
From the Emergency Department Directly to Ablation of Atrial Fibrillation Study
Role: lead
COCONUT Study Concomitant PVI and LAAC
Role: lead
Concomitant PFA Bsaed PVI Plus LAAC
Role: lead
VASC-AF Study: Vascular Closure vs Manual Compression
Role: lead
Persistent AF Catheter Ablation: Re-PVI Vs. Re-PVI + Continuous Complex Activity Mapping and Ablation - AF-CAM
Role: lead
Cancer Patient Remote Monitoring for Timely Communication Study
Role: lead
CORonaRy Angiography and intErventions Via Distal vs Proximal aCcess
Role: collaborator
Alster Stem Cells - Intramyocardial Stem Therapy
Role: lead
Impact of Pessary Treatment on Cervical Stiffness Measurement and Birth Outcomes in Patients at Risk for Preterm Birth
Role: lead
Intra-coronary Versus Intramyocardial Application of Enriched CD133pos Autologous Bone Marrow Derived Stem Cells
Role: lead
Rotablation vs Intravascular Lithotripsy in Calcified Coronary Lesions
Role: collaborator
CORONA Germany- Clinical Outcome and Risk in Hospitalized COVID-19 Patients - An Epidemiological Study From Germany
Role: lead
LUPS-Lipids and Glucose Under Prospective Surveillance
Role: lead
Noninferiority Trial of MitraClip Implantation Strategies: 1 Clip vs. 2 Clips in Patients With Functional Mitral Regurgitation
Role: lead
Harmonic vs HF Knife in Patients Requiring Abdominal Surgery
Role: lead
Long-Standing Persistant Atrial Fibrillation-Pulmonary Vein Isolation With or Without Ablation
Role: lead
Bone Marrow Derived Mononuclear Cells For Myocardial Regeneration
Role: lead
All 17 trials loaded